Cough, Cold, Or Something Worse? Why You Shouldn't Ignore Monsoon Flu Symptoms
Monsoon offers a breeding ground for the spread of viruses and bacteria. What looks like a common cold or viral fever might actually indicate something deeper.
As the monsoon clouds roll in and bring a welcome respite from the heat, there's another problem that creeps up alongside – one filled with the heightened risk of infections. While many of us dismiss the flu during the rainy months as just a product of the weather change, this approach can be dangerous. The monsoon season in India is a breeding ground for numerous infections, and flu is one of the most commonly misinterpreted illnesses. What starts as a mild cold or fever is often treated with over-the-counter remedies, including antibiotics, which can actually worsen the problem.
The onset of monsoon is accompanied by high humidity and pathogens, all of which create the perfect storm for the spread of viruses and bacteria. People often confuse flu-like symptoms with a common cold or the seasonal bug. This delay in recognising the illness can lead to more severe complications.
Dr. Mahua Das Gupta, Director of Medical Affairs (Infectious Diseases) at HaystackAnalytics, says, 'Infections caused by respiratory viruses such as Influenza A (H1N1), H3N2, SARS-CoV2 and RSV can be severe, especially for those with compromised immune systems or pre-existing conditions like asthma, diabetes, and heart disease."
The Risk of Misdiagnosis: Self-Treatment and Antibiotic Resistance
In the rush to feel better, many people opt for self-medication, often reaching for antibiotics at the first sign of fever or cold. Dr Gupta says, 'This overuse of antibiotics has contributed to a growing problem – antimicrobial resistance (AMR). The WHO identifies AMR as one of the top ten global health threats, with an estimated 5 million deaths annually attributed to drug-resistant infections."
'The overuse of antibiotics accelerates the development of antibiotic-resistant bacteria, making future infections more difficult to treat. More dangerously, the symptoms can escalate into complications like pneumonia or even organ failure, requiring hospitalizations that could have been avoided with earlier, more accurate diagnosis and appropriate treatment," adds Dr Gupta.
Early Diagnostics: The Key to Preventing Serious Illnesses
The good news is that early diagnostic tools can help prevent the flu from escalating into more severe conditions. Dr Gupta says, 'Advanced technologies, like Next-Generation Sequencing (NGS), enable clinicians to identify pathogens at the genomic level with speed and accuracy that surpass traditional methods. NGS can detect the specific virus or bacteria causing the infection, even those that are difficult to culture or detect, using older diagnostic methods."
NGS can detect a wide range of pathogens in a single test, including bacterial, fungal, and viral agents responsible for respiratory infections, and even reveal the antimicrobial resistance profiles of these pathogens. With a turnaround time as quick as 24 hours, this technology empowers clinicians to initiate the most effective treatment without delay.
How Genomics Can Help with Flu Diagnosis
NGS-based diagnostic tests can help physicians move beyond broad-spectrum antibiotics and make data-driven treatment decisions. These tests provide a clear picture of which pathogens are involved, whether viral, bacterial, or fungal, allowing for targeted treatment.
Dr Gupta explains, 'By providing a comprehensive pathogen profile, genomic tests also enable doctors to understand the exact nature of a patient's infection. Instead of relying on trial-and-error, doctors can make informed decisions about whether to prescribe antiviral medications, manage symptoms, or employ more aggressive treatments."
A Call for Vigilance: The Role of Preventive Care
As the monsoon season approaches, it's crucial to stay vigilant about flu and other infections. Flu-like symptoms during this time shouldn't be dismissed as just the weather. Early intervention with proper diagnostics can prevent complications, reduce unnecessary antibiotic use, and combat antimicrobial resistance.
view comments
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
6 hours ago
- Time of India
Study models how malaria vaccines can help mitigate climate-driven breaks in disease control
New Delhi: A study conducted in Madagascar's households has found that new malaria vaccines -- offering protection up to 10 months -- could help mitigate disruptions to disease control measures because of extreme weather events. Malaria -- a mosquito-borne infectious disease -- is a serious public health concern, with climate change-driven temperatures and rainfall creating conditions more conducive for mosquitoes to thrive and spread disease, especially in tropical countries. Researchers from the US and Madagascar in Africa said that extreme weather events, such as tropical cyclones, can hit public health infrastructure and limit people's access to malaria prevention and treatment -- this can increase infection risk, especially in high-burden regions where continuity of care and disease control is critical. However, despite concerns, data on how climate-related disruptions affect malaria control remain scarce, they said. The study, published in the journal Science, analysed 20,718 observations of malaria infection -- collected from 500 households in the African country -- before and after cyclones Batsirai (2022) and Freddy (2023) to understand how well various malaria interventions performed under the strain of extreme weather events. "In the aftermath, infection rates by the mosquito-vectored parasite increased to 10 per cent for school-aged children within three months as mosquito and malaria control activities were interrupted," the authors wrote. Brief, under-a-month-long breaks in malaria control activities, such as use of preventive medications, resulted in "rapid rebounds in infection" -- up to half of school children and over a third of younger ones were infected in high-transmission areas, the team said. Modelling strategies that may mitigate these effects in the aftermath of cyclones, the authors found that the recently introduced, WHO-recommended malaria vaccines -- 'RTS,S' and 'R21' -- could significantly reduce infection rates and help in sustaining disease control measures during breaks caused by extreme weather conditions. A vaccine coverage of 70 per cent in the population was related with a 42-52 per cent reduction in infections, the models showed. Given the figures reported by the country for routine childhood immunisation programmes, 70 per cent coverage in the population is plausible, the authors said. They wrote, "When 70 per cent of the targeted population has completed the full course for a vaccine with effectiveness of 61 to 74 per cent (reported for the R21 vaccine in phase 3 trials) before the disruptive event, a 42.7 to 51.8 per cent reduction in the expected proportion of symptomatic infections is expected." However, the team also noted that vaccines alone are not enough to arrest disease spread and that layered strategies "combining vaccines, drug-based prevention, and traditional tools like bed nets are essential, especially in high-transmission areas where malaria remains persistent".
The Hindu
8 hours ago
- The Hindu
Ernakulam witnesses spike in influenza cases
Ernakulam has recorded a spike in cases of infection caused by influenza viruses. Over 250 influenza cases had been reported over the past month, according to data provided by the Department of Health. Two students of Union Christian College, Aluva, tested positive for H1N1 influenza as of Friday (July 18). The college authorities said necessary control measures had been initiated on the instructions of the Health authorities. A total of 194 influenza cases were reported in the district between July 1 and July 17. On July 8, as many as 31 cases were recorded. A 12-year-old girl from Ayyapmpuzha had succumbed to fever on July 8, though the authorities are yet to confirm the exact reason for the death. On July 15, 32 influenza cases were reported in Ernakulam. The common strains of the influenza virus seen included H1N1, H3N2, and Influenza B. Dr. Rajeev Jayadevan, convenor of the research cell of the Indian Medical Association (IMA), Kerala, said that influenza is caused by several viruses, which circulate seasonally. 'In Kerala, the monsoon season brings two factors together. First, people crowd indoors and also travel in vehicles with windows closed due to rain. This allows respiratory viruses to spread easily. Secondly, the humid weather allows the virus to stay alive longer in the air, that is, without the tiny cough droplets drying out,' he said. He added that wearing masks in crowded indoor spaces and avoiding social visits at hospitals are two easy ways to reduce risk. 'The flu vaccine protects from severe disease. In addition, unlike COVID-19, there are effective antiviral agents available which reduce the severity of the disease if the diagnosis is made early,' he said. Some of the main symptoms include cough, tiredness, fever, runny nose, body aches, sore throat, breathlessness, and wheezing. Doctors usually advise patients to stay hydrated and to cover their mouths while coughing and sneezing. However, elderly persons with co-morbidities must take extra care.
Business Standard
11 hours ago
- Business Standard
Marengo Asia Hospitals Sets New Benchmark in Neuro & Spine Care with Launch of MAIINS
VMPL New Delhi [India], July 18: Marengo Asia Hospitals announced the launch of the Marengo Asia International Institute of Neuro & Spine (MAIINS) in Gurugram, marking a pioneering step in transforming neuroscience and spine care. The hospital has also onboarded internationally renowned neurologist Dr. Praveen Gupta to lead this institute and head the neurology department. With a multidisciplinary clinical model, MAIINS brings together neurologists, spine surgeons, psychiatrists, psychologists, pain specialists, and rehabilitation experts to provide collaborative, comprehensive, protocol-driven care across a wide range of neurological and spine conditions. Dr. Praveen Gupta is one of India's most awarded and respected neurologists. A gold medallist from AIIMS, New Delhi, Dr. Gupta has introduced several pioneering neurological treatments in the country, including Asia's first brain pacemaker for epilepsy, deep brain stimulation (DBS) for Parkinson's, and stem cell transplants for multiple sclerosis. Dr. Raajiv Singhal, Founding Member, Managing Director & Group CEO, Marengo Asia Hospitals, said,-- "At Marengo Asia Hospitals, we believe patients need to have the ease of accessing comprehensive care under one roof. With the launch of this institute, we take another significant step toward building specialised, outcome-driven Centres of Excellence that redefine accessibility, clinical leadership, and patient trust in neuro care across the region. Dr. Praveen Gupta brings not only deep clinical expertise but also a strong commitment to patient-first care, which aligns seamlessly with our vision." The institute is equipped with robotic-assisted spine surgery systems, advanced neuro-monitoring, dedicated neuro ICUs, and integrated rehabilitation services, enabling seamless pre-operative, operative, and post-operative care. Dr. Praveen Gupta, Chairman, MAIINS and Chief of Clinical Strategy, Growth and Innovation, Marengo Asia Hospitals, said, "It is a pleasure to join Marengo Asia Hospitals and head the Marengo Asia International Institute of Neuro & Spine (MAIINS). With MAIINS, our objective is to bring together clinical depth, advanced infrastructure, and preventive approach to neurological and spine health. Together, we aim to improve early diagnosis, deliver long-term disease management, and integrate mental health and geriatric neurology into mainstream care." MAIINS also introduces a clinic-based funnel model aimed at early detection and outpatient-to-inpatient continuity. Specialized clinics for memory disorders, vertigo, movement disorders, and chronic neuro-pain are designed to identify conditions at early stages and manage them proactively. Adding his views, Dr. Saurabh Lall, Facility Director, Marengo Asia Hospitals, Gurugram, said, "The launch of MAIINS marks a major leap in neurological and spine care delivery in Gurugram and surrounding regions. Located at a prime location of golf course extension road in Gurgaon, the facility is strategically positioned to serve not just the Millennium City but also key catchment areas across Delhi NCR and North India. The institute is aligned with our vision to expand our community outreach and establish clinic-based programs across residential clusters, educational institutions, and corporate hubs." A strong focus has also been placed on community-based mental health and geriatric neurology. The institute's Partial Hospitalization Program (PHP) model will offer outpatient psychological and psychiatric support for stress, anxiety, and neuropsychological resilience, targeting schools, workplaces, and residential communities. In parallel, its geriatric neurology program will deliver hyperlocal engagement and follow-up pathways for elderly patients, improving access, compliance, and outcomes. With the launch of MAIINS in Gurugram, Marengo Asia Hospitals reinforces its position as a leader in high-acuity, protocol-led healthcare provider.
